Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal Aix-Pertuis

About this trial

The goal of this observational study is to show the direct correlation between the occurrence of recurrence of VAP and postagressive immunoparalysis, monitored by HLA-DR rate below litterature-acknowledged threshold, in a well conducted antibiotherapy context, in patient admitted in the Intensive Care Unit.

The main questions it aims to answer are:

* evaluation of the association between death and persistence of immunoplegia using HLA-DR monitoring * search an association between immunoplegia depth and severity of the initial state of shock * search an association between immunoplegia depth and viral reactivation * compare association of immunoplegia duration and HLA-DR nadir and VAP occurrence Blood samples will be taken from participants to HLA-DR dosage, at the time of inclusion and once a week then.

Eligibility criteria

Qualifiers

Patient over 18 years old

Patient admitted in the Intensive Care Unit of the CHIAP

Patient under mechanical ventilation

Patient with infectious pneumonia

Disqualifiers

Patient under 18 years old

Patient with severe neutropenia (neutrophils < 0.5 G/L)

Patient under immunosuppressive treatment

Use of corticosteroids (intravenous or oral) prior to ICU admission

Trial design

Treatments tested in this trial

  • Blood collection

Treatment groups

40 Participants
are divided into 1 treatment group